Current Volume 5(2) 2000 (11)
09 Jun 2000
Cytokine Profilesas Marker for Graft Vascular Disease after Clinical Heart Transplantation
Nicole M van Besouw, Carla C Baan
Ann Transplant 2000; 5(2): 61-67 :: ID: 497528
09 Jun 2000
Cytokine Profilesas Marker for Graft Vascular Disease after Clinical Heart Transplantation
Nicole M van Besouw, Carla C Baan, Cecile T T Holweg, Hester A de Groot-Krnseman, Annemiek M A Peeters, Aggie H M M Balk, Willem Weimar
Ann Transplant 2000; 5(2): 61-67 :: ID: 497528
1,448
09 Jun 2000
Cellula rImmunology Markers Postransplantation Predictive of Long-Term Graft Outcome
Nancy L Reinsmoent, Annette M Jackson
Ann Transplant 2000; 5(2): 50-60 :: ID: 497526
09 Jun 2000
Cellula rImmunology Markers Postransplantation Predictive of Long-Term Graft Outcome
Nancy L Reinsmoent, Annette M Jackson, Angelica DeOliveira, Arthur J Matas, Kristen Gillingham, Frances E Ward
Ann Transplant 2000; 5(2): 50-60 :: ID: 497526
1,018
09 Jun 2000
Subclinical Rejection- a Potential Surrogate Marker for Chronic Rejection- May Be Diagnosed by Protocol Biopsy or Urine Spectroscopy
David Rush, Ray Somorjai
Ann Transplant 2000; 5(2): 44-49 :: ID: 497525
09 Jun 2000
Subclinical Rejection- a Potential Surrogate Marker for Chronic Rejection- May Be Diagnosed by Protocol Biopsy or Urine Spectroscopy
David Rush, Ray Somorjai, Roxanne Deslauriers, Anthony Shaw, John Jeffery, Peter Nickerson
Ann Transplant 2000; 5(2): 44-49 :: ID: 497525
1,260
24 Feb 2001
Subclinical rejection--a potential surrogate marker for chronic rejection--may be diagnosed by protocol biopsy or urine spectroscopy
D Rush, R Somorjai
Ann Transplant 2000; 5(2): 44-49 :: ID: 766708
24 Feb 2001
Subclinical rejection--a potential surrogate marker for chronic rejection--may be diagnosed by protocol biopsy or urine spectroscopy
D Rush, R Somorjai, R Deslauriers, A Shaw, J Jeffery, P Nickerson
Ann Transplant 2000; 5(2): 44-49 :: ID: 766708
1,146
09 Jun 2000
Post-Transplantation Histology as Surrogate Markerfor Long-Term Kidney Allograft Outcome
Serdar Yilmaz, Mark Nutley
Ann Transplant 2000; 5(2): 37-43 :: ID: 497524
09 Jun 2000
Post-Transplantation Histology as Surrogate Markerfor Long-Term Kidney Allograft Outcome
Serdar Yilmaz, Mark Nutley, Eero Taskinen, Timo Paavonen, Pekka Hayry
Ann Transplant 2000; 5(2): 37-43 :: ID: 497524
1,186
09 Jun 2000
Post-Transplant Glomerular Filtration Rate asa Marker for Long Term Outcome
C Pouteil-Noble, H Maiza
Ann Transplant 2000; 5(2): 29-36 :: ID: 497523
09 Jun 2000
Post-Transplant Glomerular Filtration Rate asa Marker for Long Term Outcome
C Pouteil-Noble, H Maiza, L Remontet
Ann Transplant 2000; 5(2): 29-36 :: ID: 497523
968
09 Jun 2000
Post-TransplanIt Immune Serological Markers May Be Predictive of Chronic Rejection
Ronald H Kerman,
Ann Transplant 2000; 5(2): 24-28 :: ID: 497522
09 Jun 2000
Post-TransplanIt Immune Serological Markers May Be Predictive of Chronic Rejection
Ronald H Kerman
Ann Transplant 2000; 5(2): 24-28 :: ID: 497522
908
24 Feb 2001
Post-transplant immune serological markers may be predictive of chronic rejection.
R H Kerman,
Ann Transplant 2000; 5(2): 24-28 :: ID: 766707
24 Feb 2001
Post-transplant immune serological markers may be predictive of chronic rejection.
R H Kerman
Ann Transplant 2000; 5(2): 24-28 :: ID: 766707
972
09 Jun 2000
Pharmacological Surrogates of Allograft Outcome
Kamran Mahalati, Barry D Kahan
Ann Transplant 2000; 5(2): 14-23 :: ID: 497520
09 Jun 2000
Pharmacological Surrogates of Allograft Outcome
Kamran Mahalati, Barry D Kahan
Ann Transplant 2000; 5(2): 14-23 :: ID: 497520
1,105
09 Jun 2000
Surrogate Markers of Chronic Allograft Nephropathy
L A van Es, Y W J Sijpkens
Ann Transplant 2000; 5(2): 7-11 :: ID: 497519
09 Jun 2000
Surrogate Markers of Chronic Allograft Nephropathy
L A van Es, Y W J Sijpkens, L C Paul
Ann Transplant 2000; 5(2): 7-11 :: ID: 497519
1,293
09 Jun 2000
Surrogate Biomarkers of Long-term Outcome after Kidney Transplantation
Leendert C Paul,
Ann Transplant 2000; 5(2): 5-6 :: ID: 497518
09 Jun 2000
Surrogate Biomarkers of Long-term Outcome after Kidney Transplantation
Leendert C Paul
Ann Transplant 2000; 5(2): 5-6 :: ID: 497518
1,469
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588